Moringin, an isothiocyanate modulates multiple cellular signalling molecules in breast cancer cells

Ankit Srivastava1, Shruti Mishra1, Avadhesh1

  • 1Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi 221 005, India.

Cellular Signalling
|April 21, 2024
PubMed

Insights

Prohibitin (PHB) expression impacts breast cancer survival. Moringin (MG), a natural compound, inhibits cancer cell growth by inducing apoptosis and suppressing key survival proteins, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Prohibitin (PHB) is a pleiotropic molecule with poorly understood roles in breast cancer.
  • PHB expression is altered in various cancers, correlating with reduced overall survival.

Purpose of the Study:

  • To investigate the role of PHB in breast cancer.
  • To evaluate the anti-cancer effects of Moringin (MG), an isothiocyanate from Moringa oleifera seeds.

Main Methods:

  • Assessed PHB expression in cancer patients.
  • Treated MCF-7 and MDAMB-231 breast cancer cells with MG.
  • Utilized apoptosis assays (AO/PI, phosphatidylserine externalization, cell cycle, DAPI staining).
  • Analyzed protein expression (cytochrome c, p53, caspase-7, survivin, Bcl-2, Bcl-xL, NF-κB).
  • Measured mitochondrial membrane potential and reactive oxygen species (ROS).
  • Investigated lncRNA modulation and p65 nuclear translocation.

Main Results:

  • PHB alterations correlated with reduced patient survival.
  • MG inhibited breast cancer cell growth, inducing apoptosis via mitochondrial pathways.
  • MG suppressed pro-survival proteins and modulated NF-κB signaling and lncRNAs.
  • MG treatment increased ROS generation in cancer cells.

Conclusions:

  • PHB plays a significant role in breast cancer progression.
  • Moringin exhibits potent anti-cancer activities by targeting multiple pathways, including apoptosis induction and NF-κB inhibition.
  • MG demonstrates potential as a therapeutic agent for breast cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K